These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34379994)

  • 1. SIRT1: a promising therapeutic target in type 2 diabetes mellitus.
    Mihanfar A; Akbarzadeh M; Ghazizadeh Darband S; Sadighparvar S; Majidinia M
    Arch Physiol Biochem; 2024 Feb; 130(1):13-28. PubMed ID: 34379994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential.
    Kitada M; Koya D
    Diabetes Metab J; 2013 Oct; 37(5):315-25. PubMed ID: 24199159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel SIRT1 activator E6155 improves insulin sensitivity in type 2 diabetic KKA
    Liu P; Feng T; Zuo X; Wang X; Luo J; Li N; Han X; Zhu N; Xu S; Xu Y; Jin ZG; Si S
    Biochem Biophys Res Commun; 2018 Apr; 498(3):633-639. PubMed ID: 29524414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed Tandem Effect of Physical Activity and Sirtuin 1 and 3 Activation in Regulating Glucose Homeostasis.
    Pacifici F; Di Cola D; Pastore D; Abete P; Guadagni F; Donadel G; Bellia A; Esposito E; Salimei C; Sinibaldi Salimei P; Ricordi C; Lauro D; Della-Morte D
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuins as possible drug targets in type 2 diabetes.
    Kitada M; Kume S; Kanasaki K; Takeda-Watanabe A; Koya D
    Curr Drug Targets; 2013 Jun; 14(6):622-36. PubMed ID: 23445543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Polysaccharide H-1-2 from Pseudostellaria Heterophylla Alleviates Type 2 Diabetes Mellitus.
    Fang ZH; Duan XC; Zhao JD; Wu YJ; Liu MM
    Cell Physiol Biochem; 2018; 49(3):996-1006. PubMed ID: 30196291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 and insulin resistance.
    Cao Y; Jiang X; Ma H; Wang Y; Xue P; Liu Y
    J Diabetes Complications; 2016; 30(1):178-83. PubMed ID: 26422395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N
    Zhang J; Chen Y; Liu C; Li L; Li P
    J Diabetes Res; 2020; 2020():1080152. PubMed ID: 32280711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Sirt1 and its modulators in diabetic microangiopathy: A review.
    Jin Q; Liu T; Ma F; Fu T; Yang L; Mao H; Wang Y; Peng L; Li P; Zhan Y
    Int J Biol Macromol; 2024 Apr; 264(Pt 2):130761. PubMed ID: 38467213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of therapeutic strategies targeting mitochondrial biogenesis for the treatment of insulin resistance and type 2 diabetes mellitus.
    Ding W; Yang X; Lai K; Jiang Y; Liu Y
    Arch Pharm Res; 2024 Mar; 47(3):219-248. PubMed ID: 38485900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1-FOXOs activity regulates diabetic complications.
    Jalgaonkar MP; Parmar UM; Kulkarni YA; Oza MJ
    Pharmacol Res; 2022 Jan; 175():106014. PubMed ID: 34856334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K1 inversely correlates with glycemia and insulin resistance in patients with type 2 diabetes (T2D) and positively regulates SIRT1/AMPK pathway of glucose metabolism in liver of T2D mice and hepatocytes cultured in high glucose.
    Dihingia A; Ozah D; Ghosh S; Sarkar A; Baruah PK; Kalita J; Sil PC; Manna P
    J Nutr Biochem; 2018 Feb; 52():103-114. PubMed ID: 29175667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg5 Improves Insulin Resistance and Mitochondrial Biogenesis of Liver via Regulation of the Sirt1/PGC-1α Signaling Pathway in db/db Mice.
    Zhu Y; Yang H; Deng J; Fan D
    J Agric Food Chem; 2021 Aug; 69(30):8428-8439. PubMed ID: 34309383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes.
    Imai S; Kiess W
    Front Biosci (Landmark Ed); 2009 Jan; 14(8):2983-95. PubMed ID: 19273250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of the anti-β-cell dedifferentiation mechanism of a modified Da Chaihu Decoction by an integrative approach of network pharmacology and experimental verification.
    Chen H; Guo J; Cai Y; Zhang C; Wei F; Sun H; Cheng C; Liu W; He Z
    J Ethnopharmacol; 2024 Mar; 321():117481. PubMed ID: 38007164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-93-5p participates in type 2 diabetic retinopathy through targeting Sirt1.
    Wang H; Su X; Zhang QQ; Zhang YY; Chu ZY; Zhang JL; Ren Q
    Int Ophthalmol; 2021 Nov; 41(11):3837-3848. PubMed ID: 34313929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 Diabetes Induces a Pro-Oxidative Environment in Rat Epididymis by Disrupting SIRT1/PGC-1α/SIRT3 Pathway.
    Diniz A; Alves MG; Candeias E; Duarte AI; Moreira PI; Silva BM; Oliveira PF; Rato L
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review.
    Pulla VK; Battu MB; Alvala M; Sriram D; Yogeeswari P
    Expert Opin Ther Targets; 2012 Aug; 16(8):819-32. PubMed ID: 22762724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function.
    Kitada M; Ogura Y; Monno I; Koya D
    Front Endocrinol (Lausanne); 2019; 10():187. PubMed ID: 30972029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol attenuates type 2 diabetes mellitus by mediating mitochondrial biogenesis and lipid metabolism via Sirtuin type 1.
    Cao MM; Lu X; Liu GD; Su Y; Li YB; Zhou J
    Exp Ther Med; 2018 Jan; 15(1):576-584. PubMed ID: 29387206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.